FRANKEL STUART D 3, filed Dec 13, 2006: PRIMARY DOCUMENT
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 12/13/2006 |
3. Issuer Name and Ticker or Trading Symbol
MEDecision, Inc. [ MEDE ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 2,540,763(1) | I | See Footnote(2) |
| Common Stock | 41,310(1) | I | See Footnote(3) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Series B Convertible Preferred Stock | (4) | (4) | Common Stock | 1,797,440(1) | (4) | I | See Footnote(2) |
| Series C Convertible Preferred Stock | (5) | (5) | Common Stock | 1,849,138(1) | (5) | I | See Footnote(2) |
| Series B Convertible Preferred Stock | (4) | (4) | Common Stock | 29,227(1) | (4) | I | See Footnote(3) |
| Series C Convertible Preferred Stock | (5) | (5) | Common Stock | 30,068(1) | (5) | I | See Footnote(3) |
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
| Explanation of Responses: |
| 1. The number of shares of common stock reported in Column 2 of Table I and the number of underlying shares of common stock reported in Column 3 of Table II do not reflect a one-for-two reverse stock split of the Issuer's common stock, to be effective prior to the closing of the Issuer's initial public offering. |
| 2. Grotech Partners V, L.P. ("Grotech Partners") is jointly filing this Form 3 report, and is the holder of record of the Issuer's securities listed in this line item. The designated reporting person, a director of the Issuer, is a managing general partner of the general partner of Grotech Partners. Charles P. Cullen, who is jointly filing this Form 3 report, is a director of the Issuer. Stuart D. Frankel, who is also jointly filing this Form 3 report, is a general partner of the general partner of Grotech Partners. Grotech Capital Group V, LLC is also jointly filing this Form 3 report, and is the general partner of Grotech Partners. The designated reporting person and each joint-filer disclaim beneficial ownership of all such securities held by Grotech Partners, except to the extent of their individual proportionate pecuniary interests therein. |
| 3. Grotech V Maryland Fund, L.P. ("Grotech Maryland") is jointly filing this Form 3 report, and is the holder of record of the Issuer's securities listed in this line item. The designated reporting person, a director of the Issuer, is a managing general partner of the general partner of Grotech Maryland. Charles P. Cullen, who is jointly filing this Form 3 report, is a director of the Issuer. Stuart D. Frankel, who is also jointly filing this Form 3 report, is a general partner of the general partner of Grotech Maryland. Grotech Capital Group V, LLC is also jointly filing this Form 3 report, and is the general partner of Grotech Maryland. The designated reporting person and each joint-filer disclaim beneficial ownership of all such securities held by Grotech Maryland, except to the extent of their individual proportionate pecuniary interests therein. |
| 4. Upon the closing of the Issuer's initial public offering, each share of Series B Convertible Preferred Stock held of record will automatically convert into approximately 1.262 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock held of record do not have an expiration date. |
| 5. Upon the closing of the Issuer's initial public offering, each share of Series C Convertible Preferred Stock held of record will automatically convert into 1.000 share of the Issuer's common stock. The shares of Series C Convertible Preferred Stock held of record do not have an expiration date. |
| Remarks: |
| Frank Adams | 12/13/2006 | |
| Stuart Frankel | 12/13/2006 | |
| Grotech V Maryland Fund L.P. By: Grotech Capital Group V, LLC, its General Partner By: Frank A. Adams, Managing General Partner | 12/13/2006 | |
| Grotech Partners V L.P By: Grotech Capital Group V, LLC, its General Partner By: Frank A. Adams, Managing General Partner | 12/13/2006 | |
| Grotech Capital Group V, LLC By: Frank A. Adams, Managing General Partner | 12/13/2006 | |
| Charles Cullen | 12/13/2006 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||